A basal stem cell signature identifies aggressive prostate cancer phenotypes. - Wikidata - awgldk - TriplyDB

A basal stem cell signature identifies aggressive prostate cancer phenotypes.

A basal stem cell signature identifies aggressive prostate cancer phenotypes.

http://www.wikidata.org/entity/Q36332070

about

The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem Cells ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.Distance in cancer gene expression from stem cells predicts patient survival.Advanced neuroendocrine prostate tumors regress to stemness Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer.Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.LncRNAs and miRNAs: potential biomarkers and therapeutic targets for prostate cancer T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer.Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling.Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers.Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.Databases and tools for constructing signal transduction networks in cancer.The Cohesive Metastasis Phenotype in Human Prostate Cancer.Emerging Variants of Castration-Resistant Prostate Cancer.Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.Sequencing of cancer cell subpopulations identifies micrometastases in a bladder cancer patient.Visualization of early prostatic adenocarcinoma as a stem cell disease The Role of Next-Generation Sequencing in Enabling Personalized Oncology Therapy.Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.Isolation and functional interrogation of adult human prostate epithelial stem cells at single cell resolution.v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1.Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup.Interleukin-4 induces a CD44high /CD49bhigh PC3 subpopulation with tumor-initiating characteristics.Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition.Evasion of targeted cancer therapy through stem-cell-like reprogramming.The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers.Cancer stem cells as key drivers of tumour progression.Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis.Androgen action in prostate function and disease.Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.

P2860

Q26765892-93D77DA1-26DC-4166-AE16-CC468AD20BFB Q30008747-60D07F44-F52B-4B2D-9475-350323CA9E39 Q36319754-D3AC4378-48F9-4947-A397-E44B1337A971 Q36332128-EEF15F7C-5A48-4018-9A7C-CE43125A4D29 Q36637412-058CA45A-67B2-414A-B3BD-7444CD0B2250 Q36831507-FD01C0C2-57F8-4E13-B925-A9B581975324 Q37126891-1A914407-4EEB-47CF-8780-C1653C2D6482 Q37553695-8896CD64-3475-4EAC-AE44-9A19D587880D Q37601733-5FAAA1FD-E551-45FD-8257-E036A4BD7FE4 Q37678899-79C079CD-D132-462B-838C-9E1E98D2A0F5 Q37745870-F548E3C6-2086-453B-A57E-1C6141A7F461 Q38725844-1A83F3F8-353E-43E2-8A88-DC7795ADF51E Q38758652-4EC79D5F-A785-4C27-A4C6-BB7EA2B451DC Q38762493-1EEE1ABD-C35D-495F-A9EE-419CD4598C21 Q38768101-36864C81-6587-416F-8670-F79050017783 Q38922006-DBA4FD92-A71F-47DB-96D7-CDE6D2E07FF1 Q38966462-DC5E7678-154C-4972-A538-E9A98442E026 Q39210257-0A80E96C-83A8-4345-8359-DAC009DE77F6 Q39515247-66B1145B-2D6E-4ADA-9689-180482FDEBE8 Q39683347-B5B4ED4C-3411-4D97-85EB-DC227234FE52 Q41233576-C766EA6A-5CE3-4185-BD0A-7E56E8FFBA76 Q41851423-A710857B-B06A-40D6-A482-2167F791F075 Q42204343-3DD98654-4CA9-4A0E-9C42-2B8DBD1FEDE2 Q42509592-502DA2C4-AC83-4B08-8DD0-19C151DA7536 Q42776923-8A9C03FA-727E-42E2-AD97-B9BD7ED746AE Q43931330-09AD568D-C1BA-418D-9E8A-A72465CA0458 Q44120498-50CECE71-2F17-49B4-8853-3AD9D6A01663 Q46140457-4266BB96-1A6C-47AD-B91B-C565147B2274 Q46838481-616C54D2-AF72-4460-91D1-392BFD11BB1F Q47253494-4DDE7745-2343-45D9-BC45-5F9E806DBC9B Q47727562-C8AC62CD-AF82-4E00-ADC9-3C19CF03E843 Q49787389-1C1DCF03-CDD8-4DD8-ABAC-2B2D0DC87A3F Q50284819-9DA09599-AE7D-4786-A398-E266602CBAC6 Q50286785-22106625-4236-4C3E-9F5F-F114AD43AFCB Q50889968-762E5CE2-E291-4912-A4E3-70EA05508423 Q53700061-DC41274B-C5B2-4302-AA77-D4F135743C6C Q55122201-CC922CEC-D6D8-4448-85C6-E3E82E17CEB0 Q55209569-1607FF24-816E-4323-93EB-CFD2CEA5DB93 Q55251761-813FC4D1-22A1-45AA-88B7-DFCF22D00C2A Q55291143-1D516BDD-13F1-4479-8BDB-697349863BD4

P2860

A basal stem cell signature identifies aggressive prostate cancer phenotypes.

http://www.wikidata.org/entity/Q36332070

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

A basal stem cell signature identifies aggressive prostate cancer phenotypes.

@ast

A basal stem cell signature identifies aggressive prostate cancer phenotypes.

@en

type

label

A basal stem cell signature identifies aggressive prostate cancer phenotypes.

@ast

A basal stem cell signature identifies aggressive prostate cancer phenotypes.

@en

prefLabel

A basal stem cell signature identifies aggressive prostate cancer phenotypes.

@ast

A basal stem cell signature identifies aggressive prostate cancer phenotypes.

@en

P1433

Q36332070-0EC90CB8-93B1-4FFE-AA34-FA0B662C0B61

P1476

Q36332070-00E5F9E7-7661-46D2-939D-DE4BB01D663A

P2093

Q36332070-07C5ECB1-D49C-4088-94E9-A6A747C4667A

Q36332070-125F16C9-129F-46AB-A9FB-AC857AB361BD

Q36332070-1282FE78-0F1B-4605-9C02-F5A030373E77

Q36332070-24C3C7DB-B4EA-4A14-8F4E-8B74E647D36A

Q36332070-3B9D5D69-90E7-41DA-A7FA-E80F62C42C06

Q36332070-7197A7F9-659F-4FBC-AFA7-D21498F0E6B8

Q36332070-CE079FA5-6F78-48E3-A74C-F99771E3E94A

Q36332070-D87A62DF-D67D-4D88-8919-F246A6A6A315

P2860

Q36332070-0229F115-2E30-47F6-BFC1-975C90EA7BD7

Q36332070-0770E688-7F57-49B2-A1D7-179050CC1EE6

Q36332070-0A407546-70C7-492C-A9C5-B3DA0A11E1D1

Q36332070-0B287FFA-A8D8-48C1-AF3C-51565C125197

Q36332070-0E232980-6251-4EF4-A9DB-B0B7EE078B48

Q36332070-0FC9349E-D295-42CF-BAC7-C509D28584B4

Q36332070-12CB11AF-35F8-4570-9B00-933BA1AD7228

Q36332070-150E5DE2-A0AF-4EBE-A3BB-93240EC5D4A9

Q36332070-154A2578-D62E-4795-8EFE-1DB173E32EC6

Q36332070-15929D8B-9AB7-492C-B889-A44423A09BEF

P304

Q36332070-862CD91E-5048-44D8-BF03-030B43FC8263

P31

Q36332070-285AF82B-9EE5-4270-A453-8AEB2AF2F68C

P356

Q36332070-CD400E2C-7F87-4E56-B62C-AF5004421F27

P407

Q36332070-4C48BF99-7FCF-4F7D-B515-BFBBE527D95F

P433

Q36332070-41781086-1946-407A-A143-8E0232F8C2F9

P478

Q36332070-110F05C2-AAAF-494C-9178-0B30BCD480D3

P50

Q36332070-695EA2D7-E82A-46A2-8FAE-14A7A21894CA

Q36332070-F4766AFE-CA33-4098-9AB0-1905C2E3A692

P577

Q36332070-655C47A7-D9D6-4EA6-9E7D-8970F8E47E0E

P5875

Q36332070-09608248-EAC9-4FF5-BCBA-95C6A648B35B

P698

Q36332070-959E09A1-C9DA-45CC-81A4-4FAC5A296187

P921

Q36332070-C97293ED-FF46-4F31-A254-A15569CC7607

P932

Q36332070-6AA7685B-009E-4782-9163-A499B449BB38

P356

PNAS.1518007112

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A basal stem cell signature identifies aggressive prostate cancer phenotypes

@en

P2093

Artem Sokolov

http://www.w3.org/2001/XMLSchema#string

Bryan A Smith

http://www.w3.org/2001/XMLSchema#string

Colleen Mathis

http://www.w3.org/2001/XMLSchema#string

Donghui Cheng

http://www.w3.org/2001/XMLSchema#string

Joshua M Stuart

http://www.w3.org/2001/XMLSchema#string

Owen N Witte

http://www.w3.org/2001/XMLSchema#string

Vladislav Uzunangelov

http://www.w3.org/2001/XMLSchema#string

Yulia Newton

http://www.w3.org/2001/XMLSchema#string

P2860

A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Identification of a cell of origin for human prostate cancer

Comprehensive molecular portraits of human breast tumours

The epithelial-mesenchymal transition generates cells with properties of stem cells

The many faces of neuroendocrine differentiation in prostate cancer progression

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Integrative clinical genomics of advanced prostate cancer.

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

P304

E6544-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1518007112

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Robert Baertsch

P577

2015-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282874363

http://www.w3.org/2001/XMLSchema#string

P698

26460041

http://www.w3.org/2001/XMLSchema#string

P921

P932

4664352

http://www.w3.org/2001/XMLSchema#string